Intracranial pressure monitoring in posterior fossa lesions-systematic review and meta-analysis.

Infratentorial ICP measurement Intracranial pressure monitoring Posterior fossa lesion Supratentorial ICP measurement Transtentorial gradient

Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 07 12 2021
accepted: 27 01 2022
revised: 25 01 2022
pubmed: 5 2 2022
medline: 7 6 2022
entrez: 4 2 2022
Statut: ppublish

Résumé

Elevated intracranial pressure (ICP) with reduced cerebral perfusion pressure is a well-known cause of secondary brain injury. Previously, there have been some reports describing different supra- and infratentorial ICP measurements depending on the location of the mass effect. Therefore, we aimed to perform a systematic review and meta-analysis to clarify the issue of optimal ICP monitoring in the infratentorial mass lesion. A literature search of electronic databases (PUBMED, EMBASE) was performed from January 1969 until February 2021 according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement. Two assessors are independently screened for eligible studies reporting the use of simultaneous ICP monitoring in the supra- and infratentorial compartments. For quality assessment of those studies, the New Castle Ottawa Scale was used. The primary outcome was to evaluate the value of supra- and infratentorial ICP measurement, and the secondary outcome was to determine the time threshold until equalization of both values. Current evidence surrounding infratentorial ICP measurement was found to be low to very low quality according to New Castle Ottawa Scale. Eight studies were included in the systematic review, four of them containing human subjects encompassing 27 patients with infratentorial pathology. The pooled data demonstrated significantly higher infratentorial ICP values than supratentorial ICP values 12 h after onset (p < 0.05, 95% CI 3.82-5.38) up to 24 h after onset (p < 0.05; CI 1.14-3.98). After 48-72 h, both ICP measurements equilibrated showing no significant difference. Further, four studies containing 26 pigs and eight dogs showed a simultaneous increase of supra- and infratentorial ICP value according to the increase of supratentorial mass volume; however, there was a significant difference towards lower ICP in the infratentorial compartment compared to the supratentorial compartment. The transtentorial gradient leads to a significant discrepancy between supra- and infratentorial ICP monitoring. Therefore, infratentorial ICP monitoring is warranted in case of posterior fossa lesions for at least 48 h.

Identifiants

pubmed: 35118578
doi: 10.1007/s10143-022-01746-y
pii: 10.1007/s10143-022-01746-y
pmc: PMC9160102
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1933-1939

Informations de copyright

© 2022. The Author(s).

Références

Neurosurgery. 1987 Nov;21(5):688-92
pubmed: 3696403
Br J Neurosurg. 1999 Oct;13(5):454-8
pubmed: 10627774
Crit Care Med. 2002 Feb;30(2):435-41
pubmed: 11889326
Br J Neurosurg. 2017 Oct;31(5):557-563
pubmed: 28539078
Turk Neurosurg. 2015;25(5):712-20
pubmed: 26442536
J Neurosurg. 1989 Oct;71(4):503-5
pubmed: 2795169
J Neurosurg. 2013 Dec;119(6):1583-90
pubmed: 24098983
J Neurosurg. 1982 May;56(5):660-5
pubmed: 7069478
Intensive Care Med. 2019 Dec;45(12):1819-1821
pubmed: 31616963
J Neurosurg. 1999 Jan;90(1):16-26
pubmed: 10413151
J Neurosurg. 1997 Mar;86(3):505-10
pubmed: 9046308
Neurology. 2001 Jun 26;56(12):1746-8
pubmed: 11425944
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Neurol Res. 2003 Dec;25(8):880-4
pubmed: 14669535
Acta Neurochir Suppl. 2016;122:37-40
pubmed: 27165873
Surg Neurol. 1990 Apr;33(4):296-7
pubmed: 2326736
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):813-21
pubmed: 15145991
Br J Neurosurg. 2021 Apr;35(2):129-132
pubmed: 32410470
J Neurosurg. 1996 Apr;84(4):642-7
pubmed: 8613857
Neurosurg Focus. 2013 May;34(5):E8
pubmed: 23634927

Auteurs

Sae-Yeon Won (SY)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany. sae-yeon.won@med.uni-rostock.de.

Daniel Dubinski (D)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Jonas Hagemeier (J)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Bedjan Behmanesh (B)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Svorad Trnovec (S)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Joshua D Bernstock (JD)

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

Thomas M Freiman (TM)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Florian Gessler (F)

Department of Neurosurgery, University Hospital Rostock, Schillingallee 35, 18057, Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH